Jianmei Wang
Welwyn Garden City, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Journal: Therapeutic advances in neurological disorders
Published: March 05, 2024
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab.
Journal: Advances in rheumatology (London, England)
Published: May 21, 2019
Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.
Journal: The Journal of rheumatology
Published: December 19, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients.
Journal: The pharmacogenomics journal
Published: May 05, 2017
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources.
Journal: Rheumatology and therapy
Published: June 04, 2016
Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis.
Journal: Arthritis care & research
Published: June 09, 2015
IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis.
Journal: BMJ open
Published: August 21, 2013
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.
Journal: Annals of the rheumatic diseases
Published: June 13, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026